Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search


Translational Research For The Benefit Of Public Health

Translational Research For The Benefit Of Public Health

by Shobha Shukla
May 5, 2014

Translational research is scientific research that helps to make findings from basic science useful for improving human health and well-being. It is basically a three steps process: (i) doing laboratory research on a medical issue like cause of a medical condition or a specific treatment (ii) studying the efficacy of positive research findings through clinical trials on human volunteers, and (iii) finally making available the findings to the general population in the form of treatment.

Speaking to Citizen News Service (CNS) during the recently concluded "International Conference on Emerging Frontiers and Challenges in Management and Control of STIs and HIV" organized by the National Institute for Research in Reproductive Health (NIRRH), Indian Council of Medical Research (ICMR), and MGM Institute of Health Sciences in Mumbai. Professor (Dr) Nirmal Kumar Ganguly, former Director General of ICMR and senior advisor of Translational Health Science and Technology Institute at National Institute of Immunology (NII), said that, "Translational research involves converting a basic research idea into a product; then developing that product for industrial production and finding out if it is safe and efficacious; and finally using it to improve public health. This is the line of translation."

Dr Ganguly informed that, “This kind of work has started in India, but it is going to take some time for us to become a major player in this field. Based upon some of our research/tests done at the basic level in our country, some products have been developed globally like the injectable contraceptive. We taught our neighbours Egypt, Indonesia, Bangladesh with elegant trials. Unfortunately we have not been able to use it but they have used it with tremendous efficaciousness in their population. Amelioration of post partum haemorrhage was also a big translation which prevented deaths in women.”

However, as Dr Nancy R Reynolds, Professor, Yale University, rued, there are many stumbling blocks on the path which connect application of knowledge from basic science to development of strategies/products for improving public health, partially due to the compartmentalization within science, career and funding disincentives. She said that the median time between the publication of a new discovery in a basic science journal to the publication of ‘use’ of this discovery in a highly cited medical journal is very long--around 24 years.

Implementation science recognizes and addresses the multitude of gaps that impede evidence based interventions (EBIs) from producing optimal health outcomes. It offers a promising way to integrate research, policy and practice for more effective prevention and treatment of target populations, by addressing the major bottlenecks that impede effective implementation. It thus helps the translational science process to deliver efficacious treatments to patients faster.

The female condom (FC) is just one example of an effective research product that has not had the desired public health benefits in India. FC was developed as a powerful female controlled tool to protect women from unintended pregnancies and also from STIs including HIV. But in the absence of any proper advocacy, even after 21 years of its approval by the US FDA (in 1993), its uptake in India has been minimal. Indian policy makers are yet to figure out how to programmatically introduce FC so that it can result in public health outcomes such as reducing rates of unintended pregnancies, STIs and HIV.

In Dr Ganguly’s opinion, “In a typical Indian household, women are not the decision makers and it is highly unlikely that they will go out and buy a condom from a medical shop. So we need to make FCs more accessible to them. We should also have family counselling and empower women to be the decision makers at least where their own health is concerned. Even the government is not very clear about how and to what extent the female condom should be promoted. On the other hand, the emergency contraceptive pill is being used a lot, just because it was advertised in a big way even though it is often being over used for wrong reasons.”

Many people living with HIV or at risk of HIV do not have access to, or get prevention treatment and care, despite the tremendous advances made in the field of HIV treatment. This is true of other STIs as well. Dr Reynolds rightly lamented that EBIs are often developed in trials that establish efficacy without consideration of local context. They have been successful in demonstrating efficacy in reducing HIV risk in randomized controlled trials but not in real life situations which could be very different. Prevention scientists have designed at least 144 EBIs to reduce HIV transmission acts. Yet these programmes have not been broadly diffused. There is also lack of clarity on which interventions should be scaled up (for example should India offer Pre-Exposure Prophylaxis (PrEP)/ Post-Exposure Prophylaxis (PEP) for HIV?) or on factors (like fidelity or acceptability) influencing success and failure of scale up attempts.

Experts also advocated that social and behavioural contexts and implementation science should be given due thought early on in the research process. Basic science should not be progressing in isolation but should be taking implementation and translational research into consideration while moving forward.

Hence, for a successful public health impact, technologies should not be developed without paying adequate attention to social and behavioural sciences. Future efforts call for innovative and integrated approaches to prevention and treatment that are structured to the social, cultural, and institutional contexts of vulnerable populations. There is need to stimulate translational milestone driven research that will have desired public health outcomes to control unwanted pregnancies, STIs and HIV, taking into account local health practices, safety, efficacy, acceptability and cost within the target population.


Shobha Shukla is the Managing Editor of Citizen News Service - CNS. She is a J2J Fellow of National Press Foundation (NPF) USA and received her editing training in Singapore. She has earlier worked with State Planning Institute, UP and taught physics at India's prestigious Loreto Convent. She also co-authored and edited publications on childhood TB, childhood pneumonia, Hepatitis C Virus and HIV, violence against women and girls, and MDR-TB.

© Scoop Media

Top Scoops Headlines


Gordon Campbell: On The Lancet’s Stance Against The Olympic Games, And On The US Culture Battles Over Abortion

Yesterday - barely a month before the opening ceremony - the Lancet medical journal has called for a global conversation on whether the Olympics should go ahead. But who is able to take part in that conversation? Not the hosts, evidently. In poll after poll, a huge majority of the Japanese people have made it clear they do not want to host the Games... More>>

Binoy Kampmark: Vague Alternatives And G7 Summitry: The Build Back Better World Initiative

Summits often feature grand statements and needless fripperies. In Cornwall, the leaders of the G7 countries were trying to position and promote their relevance as the vanguard of democratic good sense and values... More>>

Suicidal Games: Tokyo’s Coronavirus Olympics

A pandemic crisis. A state of emergency. Overwhelming public opinion bristling with alarm. Notwithstanding these factors, Tokyo is still on track to host the Olympics that was cancelled last year in response to the global pandemic. The first sports team – Australia’s softball crew – has touched down. Is all this folly, bravery or self-interest?.. More>>

How It All Went Wrong: The Global Response To COVID-19

The Independent Panel for Pandemic Preparedness and Response was never likely to hand down a rosy report with gobbets of praise. Organised by the World Health Organization Director-General Tedros Adhanom Ghebreyesus last May, the panel’s gloomy assessment was grim: the COVID-19 pandemic could have been avoided... More>>

The Conversation: Is Natural Gas Really Cheaper Than Renewable Electricity?

Climate Explained is a collaboration between The Conversation, Stuff and the New Zealand Science Media Centre to answer your questions about climate change... More>>

Keith Rankin: The New Zealand Government’s 'Public Finance Rabbithole'

Last week, out of left field, the government placed a three-year embargo on normal public sector wage bargaining, essentially a salary freeze. While there has been a certain amount of backtracking since, it is clear that the government has been ... More>>